Charles C H Chan is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of intravascular diagnosis, holding a total of 3 patents. His work focuses on developing advanced medical devices that enhance diagnostic capabilities.

Latest Patents

One of his latest patents is an apparatus and method for intravascular measurements. This invention includes a monitoring guidewire and a display unit. The monitoring guidewire consists of a core wire and a sensor located in the distal region of the core wire. The display unit is equipped with a processor and a display screen, allowing it to receive communications from the monitoring guidewire. It performs computations based on these communications and displays relevant information on the screen. Additionally, the display unit can be designed to be disposed of after a certain number of uses or a predetermined duration of use. Another patent in this area also involves a monitoring guidewire made from materials such as MP35N, L605, Elgiloy, and an alloy of nickel, cobalt, molybdenum, and chromium, with a housing that is more flexible than the core wire.

Career Highlights

Charles C H Chan is currently associated with Zurich Medical Corporation, where he continues to innovate in the medical technology sector. His work has been instrumental in advancing intravascular diagnostic methods, which are crucial for patient care.

Collaborations

He has collaborated with notable colleagues, including Kin-Joe Sham and James V Donadio, III, contributing to the development of cutting-edge medical technologies.

Conclusion

Charles C H Chan's contributions to intravascular diagnosis through his patents and collaborations highlight his role as a significant innovator in the medical field. His work continues to impact the way intravascular measurements are conducted, ultimately benefiting patient outcomes.